Literature DB >> 16443077

An acneiform eruption due to erlotinib: prognostic implications and management.

Susan Journagan, Joseph Obadiah.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16443077     DOI: 10.1016/j.jaad.2005.08.033

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

Review 1.  Folliculitis induced by EGFR inhibitors, preventive and curative efficacy of tetracyclines in the management and incidence rates according to the type of EGFR inhibitor administered: a systematic literature review.

Authors:  Jean-Baptiste Bachet; Lucie Peuvrel; Claude Bachmeyer; Ziad Reguiai; Pierre A Gourraud; Olivier Bouché; Marc Ychou; Rene J Bensadoun; Brigitte Dreno; Thierry André
Journal:  Oncologist       Date:  2012-03-16

2.  When bugs and drugs conspire: driving acneiform skin toxicity.

Authors:  Allison C Billi; Mrinal K Sarkar; Johann E Gudjonsson
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

3.  Neutralization of IL-8 prevents the induction of dermatologic adverse events associated with the inhibition of epidermal growth factor receptor.

Authors:  Nannie Bangsgaard; Mischa Houtkamp; Danita H Schuurhuis; Paul W H I Parren; Ole Baadsgaard; Hans W M Niessen; Lone Skov
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

4.  Review of erlotinib in the treatment of advanced non-small cell lung cancer.

Authors:  Kristen N Ganjoo; Heather Wakelee
Journal:  Biologics       Date:  2007-12

5.  Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors.

Authors:  Xuan Huang; Samir Patel; Nasir Ahmed; Karen Seiter; Delong Liu
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.